Two studies demonstrated that higher expression of HIF1A encoding for HIF-1α and lower HIF-2α levels are associated with resistance to PT2399 (a derivative of belzutifan) in RCC models [32,33]. This evidence concerns the gene EPAS1 and renal cell carcinoma.